Reumat ConsultingApr 9, 2020Trial enrollment investigations pollFierceBiotech report on trial enrollment investigations. https://www.fiercebiotech.com/biotech/pandemic-sees-one-quarter-investigators-ha...
Reumat ConsultingApr 9, 2020Availability of medicines used in the COVID-19 pandemicEuropean Medicines Authority report on EU authorities support of availability of medicines used in the COVID-19 pandemic...
Reumat ConsultingMay 21, 2018PV Audit and Inspection Hosting - PIPA conferenceMichael Ramcharan of Reumat Consulting will be hosting a session at the two-day Pharmaceutical Information and Pharmacovigilance...
Reumat ConsultingMay 17, 2018Global Clinical Trials Connect Conference 2018Michael Ramcharan of Reumat Consulting recently chaired the 2018 Global Clinical Trials Connect conference in London. The two day...
Reumat ConsultingMar 15, 2018WEBINAR - Remote Auditing in Pharmacovigilance (PV)Michael Ramcharan of Reumat Consulting will be presenting a Webinar entitled "Remote Auditing in Pharmacovigilance (PV)" on Tuesday 22...
Reumat ConsultingDec 20, 2017New Pharmacovigilance Obligations for MAHs in IndiaDIA Global Forum Regional Editor for India, J. Vijay Venkatraman, reports on the new pharmacovigilance obligations for MAHs in India....
Reumat ConsultingNov 30, 2016Adverse Drug Reactions to Human Medicines in South AfricaSouth Africa – POST-MARKETING REPORTING OF ADVERSE DRUG REACTIONS TO HUMAN MEDICINES IN SOUTH AFRICA The South African MCC (Medicines...